tamoxifen sandoz 30 mg filmdragerad tablett
sandoz a/s - tamoxifencitrat - filmdragerad tablett - 30 mg - tamoxifencitrat 45,6 mg aktiv substans; laktosmonohydrat hjälpämne - tamoxifen
tamoxifen sandoz 40 mg filmdragerad tablett
sandoz a/s - tamoxifencitrat - filmdragerad tablett - 40 mg - tamoxifencitrat 60,8 mg aktiv substans; laktosmonohydrat hjälpämne - tamoxifen
tamoxifen mylan 40 mg tablett
mylan ab - tamoxifencitrat - tablett - 40 mg - mannitol hjälpämne; tamoxifencitrat 60,8 mg aktiv substans - tamoxifen
nolvadex 10 mg tablett
astrazeneca ab - tamoxifencitrat - tablett - 10 mg - laktosmonohydrat hjälpämne; tamoxifencitrat 15,2 mg aktiv substans - tamoxifen
nolvadex 20 mg tablett
astrazeneca ab - tamoxifencitrat - tablett - 20 mg - laktosmonohydrat hjälpämne; tamoxifencitrat 30,4 mg aktiv substans - tamoxifen
nolvadex 40 mg tablett
astrazeneca ab - tamoxifencitrat - tablett - 40 mg - tamoxifencitrat 60,8 mg aktiv substans; laktosmonohydrat hjälpämne - tamoxifen
verzenios
eli lilly nederland b.v. - abemaciclib - bröst-neoplasmer - antineoplastiska medel - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.
aromasin 25 mg dragerad tablett
pfizer ab - exemestan - dragerad tablett - 25 mg - sackaros hjälpämne; exemestan 25 mg aktiv substans; mannitol hjälpämne; metylparahydroxibensoat hjälpämne - exemestan
exemestane accord 25 mg filmdragerad tablett
accord healthcare b.v. - exemestan - filmdragerad tablett - 25 mg - exemestan 25 mg aktiv substans; mannitol hjälpämne - exemestan
exemestan sandoz 25 mg filmdragerad tablett
sandoz a/s - exemestan - filmdragerad tablett - 25 mg - exemestan 25 mg aktiv substans; mannitol hjälpämne - exemestan